|
1
|
Hershko A and Ciechanover A: The ubiquitin
system. Annu Rev Biochem. 67:425–479. 1998. View Article : Google Scholar
|
|
2
|
Mani A and Gelmann EP: The
ubiquitin-proteasome pathway and its role in cancer. J Clin Oncol.
23:4776–4789. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ardley HC and Robinson PA: E3 ubiquitin
ligases. Essays Biochem. 41:15–30. 2005. View Article : Google Scholar
|
|
4
|
van der Reijden BA, Erpelinck-Verschueren
CA, Lowenberg B and Jansen JH: TRIADs: a new class of proteins with
a novel cysteine-rich signature. Protein Sci. 8:1557–1561.
1999.PubMed/NCBI
|
|
5
|
Marteijn JA, van Emst L,
Erpelinck-Verschueren CA, et al: The E3 ubiquitin-protein ligase
Triad1 inhibits clonogenic growth of primary myeloid progenitor
cells. Blood. 106:4114–4123. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Jung JH, Lee SM, Bae S, et al: Triad 1
induces apoptosis by p53 activation. FEBS lett. 584:1565–1570.
2010. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Wang H, Bei L, Shah CA, Horvath E and
Eklund EA: HoxA10 influences protein ubiquitination by activating
transcription of ARIH2, the gene encoding Triad1. J Biol Chem.
286:16832–16845. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Chu MC, Selam FB and Taylor HS: HOXA10
regulates p53 expression and matrigel invasion in human breast
cancer cells. Cancer Biol Ther. 3:568–572. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Chi XZ, Kim J, Lee YH, et al: Runt-related
transcription factor RUNX3 is a target of MDM2-mediated
ubiquitination. Cancer Res. 69:8111–8119. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Dai MS, Shi D, Jin Y, et al: Regulation of
the MDM2-p53 pathway by ribosomal protein L11 involves a
post-ubiquitination mechanism. J Biol Chem. 281:24304–24313. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Jin Y, Zeng SX, Lee H and Lu H: MDM2
mediates p300/CREB-binding protein-associated factor ubiquitination
and degradation. J Biol Chem. 279:20035–20043. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Leng RP, Lin Y, Ma W, et al: Pirh2, a
p53-induced ubiquitin-protein ligase, promotes p53 degradation.
Cell. 112:779–791. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Momand J, Zambetti GP, Olson DC, George D
and Levine AJ: The mdm-2 oncogene product forms a complex with the
p53 protein and inhibits p53-mediated transactivation. Cell.
69:1237–1245. 1992. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Faderl S, Kantarjian HM, Estey E, et al:
The prognostic significance of p16(INK4a)/p14(ARF) locus deletion
and MDM-2 protein expression in adult acute myelogenous leukemia.
Cancer. 89:1976–1982. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Fulci G, Labuhn M, Maier D, et al: p53
gene mutation and ink4a-arf deletion appear to be two mutually
exclusive events in human glioblastoma. Oncogene. 19:3816–3822.
2000. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Pasmant E, Laurendeau I, Heron D, Vidaud
M, Vidaud D and Bieche I: Characterization of a germ-line deletion,
including the entire INK4/ARF locus, in a melanoma-neural system
tumor family: identification of ANRIL, an antisense noncoding RNA
whose expression coclusters with ARF. Cancer Res. 67:3963–3969.
2007. View Article : Google Scholar
|
|
17
|
Midgley CA, Desterro JM, Saville MK, et
al: An N-terminal p14ARF peptide blocks Mdm2-dependent
ubiquitination in vitro and can activate p53 in vivo. Oncogene.
19:2312–2323. 2000. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Zhang Y, Xiong Y and Yarbrough WG: ARF
promotes MDM2 degradation and stabilizes p53: ARF-INK4a locus
deletion impairs both the Rb and p53 tumor suppression pathways.
Cell. 92:725–734. 1998. View Article : Google Scholar : PubMed/NCBI
|
